A clinical study to evaluate the effect of purnayavaniarka nebulization in wheezing children

A controlled comparative clinical study to evaluate the bronchodilator effect of parnayavani arka nebulisation in wheezing children

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047398

Enrollment

154

Registered

2022-11-17

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J22- Unspecified acute lower respiratory infection

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex. Patients between age group of 6-14 years Patients having wheezing on chest auscultation Patients consenting to be included in the study

Exclusion criteria

Exclusion criteria: Exclusion criteria: Known case of tuberculosis or any other acute and grave infection. Patients with history of malignancy Patients with congenital anatomical abnormalities of chest and respiratory system Patients in life- threatening conditions viz,- respiratory acidosis, diabetic ketoacidosis, Respiratory Distress Syndrome etc.

Design outcomes

Primary

Measure	Time frame
Will assess whether Parnayavani Arka Nebulization helps in reducing symptom wheezing with the help of GINA assessment scaleTimepoint: Every 6th hour will check for the improvement of symptoms for two days and will take follow ups on 5th and 7th day	—

Secondary

Measure	Time frame
Is parnayavani arka nebulization more effective than salbutamol nebulizationTimepoint: First 2 days 5th day 7th day	—

Countries

India

Contacts

Public ContactDr Sudhirkumar Pani

Parul Institute of Ayurved

sudhirkumar.pani86258@paruluniversity.ac.in79843143363

Outcome results